SCHEMBL8767909

SCHEMBL8767909

CS(=O)(=O)c1ccc(CN2CCC2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.49
PRMT5 O14744 2/20 0.46
WDR77 Q9BQA1 2/20 0.46
HRH3 Q9Y5N1 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
POLB P06746 1/20 0.43
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CCR2 P41597 1/20 0.42
PTGS2 P35354 1/20 0.42
ACACB O00763 1/20 0.42
KCNJ1 P48048 1/20 0.41
KCNH2 Q12809 1/20 0.41
CYP11B2 P19099 1/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15972059 0.80 ALDH1A1 (0.42) PRMT5WDR77LMNACCR2PTGS2
SCHEMBL28801601 0.75 ALDH1A1 (0.61) L3MBTL1HRH3POLBLMNASMN1; SMN2
SCHEMBL8766483 0.75 GSR (0.47) LMNASMN1; SMN2
SCHEMBL8766562 0.75 L3MBTL1 (0.50) L3MBTL1HRH3POLBLMNASMN1; SMN2
SCHEMBL11432095 0.75 GAA (0.68) L3MBTL1POLBSMN1; SMN2ACACB
SCHEMBL7389188 0.74 L3MBTL1 (0.73) L3MBTL1HRH3POLB
SCHEMBL3919431 0.74 L3MBTL1 (0.54) L3MBTL1HRH3CA12CA1CA2
SCHEMBL3369476 0.73 PTGDR2 (0.42) PRMT5WDR77POLBPTGS2KCNH2
SCHEMBL8236801 0.72 HRH3 (0.64) HRH3LMNACCR2
SCHEMBL11200681 0.72 L3MBTL1 (0.76) L3MBTL1HRH3SMN1; SMN2ACACBKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788478-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-08-13 EP disclosed